學門類別
最新個案
- Leadership Imperatives in an AI World
- Vodafone Idea Merger - Unpacking IS Integration Strategies
- V21 Landmarks Pvt. Ltd: Scaling Newer Heights in Real Estate Entrepreneurship
- Snapchat’s Dilemma: Growth or Financial Sustainability
- Did I Just Cross the Line and Harass a Colleague?
- Predicting the Future Impacts of AI: McLuhan’s Tetrad Framework
- Porsche Drive (A) and (B): Student Spreadsheet
- Porsche Drive (B): Vehicle Subscription Strategy
- TNT Assignment: Financial Ratio Code Cracker
- Winsol: An Opportunity For Solar Expansion
Theranos Inc.: A Revolutionary Blood-Testing Start-Up Too Good To Be True? (A)
內容大綱
This case series focuses on Theranos Inc. (Theranos), a health care technology start-up founded by Elizabeth Holmes in 2003. Theranos focused on developing a revolutionary blood-testing technology that was supposed to be able to detect diseases using only a few drops of blood. Once valued at US$10 billion, the company never demonstrated its alleged technological breakthrough, and Holmes was eventually charged by the Securities and Exchange Commission for fraud and deceit. In 2018, Theranos was forced to shut down its operations, and in January 2022, Holmes was found guilty of three counts of wire fraud and one count of conspiracy to commit wire fraud. The case series explores Theranos’s history, as well as the role of overconfidence bias in Theranos’s downfall.
學習目標
This case series has been designed for use at the undergraduate and graduate levels and can be used in courses related to health leadership and innovation, health ethics, and business law. By working through the case series and assignment questions, students will have the opportunity to do the following:<br><br><ul><li>Explore the implications of blind ambition and overconfidence bias in health care innovations.</li><li>Analyze a health care ethics case from the perspectives of different stakeholders.</li><li>Understand the importance of compliance and the role of organizations such as the Food and Drug Administration, and the Centers for Medicare & Medicaid Services.</li><li>Explore how the pressures of Silicon Valley create misaligned values.</li></ul>